The Pakistan International Airlines' (PIA) order has come in the...
Category:
Health
Latest
Empowering youth with accurate information on sexual reproductive health
``We believe that when young people are equipped with accurate,...
EU parliament to extend new medicine data protection to 7.5 years, document says
The legislation, proposed by the European Commission in April last...
Xiaomi to offer full spectrum of financial services, adds insurance vertical to its India platform
Xiaomi is adding insurance vertical to its platform as well as expanding the lending category with the addition of offerings like gold loans and credit line cards.
Xiaomi India Financial Services Head Ashish Khandelwal said Xiaomi has partnered with ICICI Lombard to curate a health insurance product.
Xiaomi also has a cyber insurance offering, and more than 25,000 customers have been covered so far.
”Going ahead, insur-tech is another proposition that we are working on in a curated manner in partnerships,” he added.
Three insurance-related firms to raise Rs 10,000 cr through IPOs
Policybazaar’s Rs 6,017.5-crore public issue comprises a fresh issue of Rs 3,750 crore and an offer-for-sale of Rs 2,267.5 crore by existing selling shareholders
Star Health, the largest standalone private health insurer, is planning to raise Rs 3,000 crore; while Medi Assist, which is the largest third-party administrator, is lining up a Rs 840-1,000 crore issue, according to their draft red herring prospectus (DRHP) filed with the market watchdog.
The cost of saving global economy: $834 million an hour for 18 months
With central banks sucking up so much of the bond market and forcing down borrowing costs, there’s now more than $16 trillion in debt with a negative yield. And it’s part of the reason why money managers say they’ve got no alternative except to keep buying up stocks.
Hope to start supply of ZyCoV-D vaccine by mid to end Sept: Zydus Group MD
The company’s indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on Friday, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.
Severe Covid-19 breakthrough cases mostly in older, sicker patients: Doctors
Such “breakthrough” cases have become central to a global debate over whether highly vaccinated countries should give booster doses of Covid-19 vaccines, and to which people. Israel began offering booster doses to people age 60 and up in July, and has since expanded that eligibility.
The United States, citing data out of Israel and other findings, said on Wednesday it would make booster doses available to all Americans beginning in September.
July non-life insurance premiums shrug off pandemic cloud: Care Ratings
Non-life insurance premium reached Rs 20,171 crore compared to Rs 16,885 crore in July 2020. The growth was driven by health and fire segments with motor segment also turning in positive numbers.
J&J seeks nod for COVID-19 vaccine trial in Indian adolescents
Conducting vaccine clinical trials among adolescents is imperative to achieve herd immunity against the coronavirus, J&J said in an emailed statement.
The U.S. pharma giant had received emergency use approval for its single-dose vaccine in India earlier this month, making it the fifth authorised vaccine in the country. read more
India approves Zydus Cadila’s ZyCoV-D vaccine for emergency use for adults and children above 12 yrs
Chairperson of the Zydus Group, Pankaj R Patel said, “We are extremely happy that our efforts to put out a safe, well-tolerated and efficacious vaccine to fight COVID-19 has become a reality with ZyCoV-D. To create the world’s first DNA vaccine at such a crucial juncture and despite all the challenges, is a tribute to the Indian research scientists and their spirit of innovation. I’d like to thank the Department of Biotechnology under the Government of India for their support in this mission of Atma Nirbhar Bharat and Indian Vaccine Mission COVID Suraksha.”
WHO seeks ‘best minds’ to probe new pathogens that jump from animals to humans
“In the last 20 years we’ve had many of these pathogens emerge or re-emerge: SARS, MERS, different avian influenzas, Zika, yellow fever and of course SARS-CoV-2,” van Kerkhove said.
Recovered Covid patients can donate kidneys: Study
Gulati said there was an apprehension that in case the person donating the kidney was someone who recovered from COVID-19, a low degree of coronavirus could be transferred to the recipient during the transplant process.